1. Books and Publications

2. Transdermal Delivery Laboratory 

      Selected Research Projects

Pfizer (New York, NY)

• Microneedles alone or in combination with other enhancement techniques for transdermal delivery of proteins

• Enhancement methods for transdermal delivery of proteins

Abbott/AbbVie Laboratories (Abbott Park, IL)

• Permeation enhancement of a hormonal gel

GlaxoSmithKline (Parsipanny, NJ)

• In vitro release testing and intradermal/transdermal delivery
• Topical delivery of pharmaceuticals & herbals
• Intradermal/topical and transdermal product development
• Skin permeation of drugs
• Iontophoretic transdermal delivery of drugs
• Transdermal delivery of drugs - issues and innovations

• Skin permeation of H2-receptor antagonist

Johnson & Johnson

• Skin permeation studies

Verde/NIDA

• In-Home Deactivation Systems for Psychoactive Drugs, National Institute of Drug Abuse, PI Dr. Andrew G. Korey, Verde Environmental Technologies, Inc. Funded as a Phase II Small Business Innovation Research Grant to develop/improve a commercial product to safely dispose of unused medications in households

Merck Millipore (Germany)

• Use of polyvinyl alcohol in transdermal patches 

Solvay Pharmaceuticals (Marietta, GA)

• Skin permeation studies of drug formulations

Solvay Pharmaceuticals B.V. (the Netherlands)

• Screening of therapeutic chemical/biological entities for transdermal and/or iontophoretic delivery

Agile Therapeutics (Princeton, NJ)

• Formulation factors affecting skin permeation of hormones from a Transdermal patch

Travanti Pharma (Teikoku Pharma;  MN)

• Modulated drug delivery through skin by iontophoresis and sampling by microdialysis
• Modulated transdermal drug delivery by iontophoresis
• Enhanced in vivo transdermal drug delivery by iontophoresis

• Analysis of medication disposal kits designed to deactivate unused, residual, or expired medications, Travanti Pharma Inc.

Murty Pharmaceuticals (Lexington, KY)

• In vivo transdermal delivery of tetrahydrocannabinol formulations
• Transdermal delivery of tetrahydro-cannabinol

Skin Medica (Carlsbad, CA)

• Formulation development, skin irritation, and efficacy characterization of cosmeceuticals 

• Strategies to increase and measure dermal levels of cosmeceuticals 

• Enhancement strategies for delivery of cosmeceuticals

• Formulation development, stability testing, and delivery of skin lightening agents

Transport Pharmaceuticals (Framingham, MA)

• Transdermal drug delivery by a combination of microneedles and iontophoresis

• Evaluation of terbinafine and other drug cartridges for iontophoretic release and transdermal delivery 

• Evaluation of acyclovir formulations in iontophoretic drug cartridges
• Evaluation of drugs for iontophoretic delivery to control acne and psoriasis

Altea Therapeutics (Atlanta, GA)

• Transdermal delivery of proteins and peptides by thermal microporation
• Transdermal delivery of Small molecules by thermal microporation
• Delivery of parathyroid hormone through microporated skin
• Enhanced insulin delivery by microporation and other active energy based flux enhancement
• Enhanced in vivo insulin delivery by microporation and other active energy based flux enhancement
• Enhanced in vitro insulin delivery by microporation and other active energy based flux enhancement
• Delivery of pDNA and protein antigens through microporated skin
• Formulation and delivery of interferon